Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

Abstract:

:Myeloma is a unique hematologic malignancy that exclusively homes in the bone marrow and induces massive osteoclastic bone destruction presumably by producing cytokines that promote the differentiation of the hematopoietic progenitors to osteoclasts (osteoclastogenesis). It is recognized that neighboring bone marrow stromal cells influence the expression of the malignant phenotype in myeloma cells. This study examined the role of the interactions between myeloma cells and neighboring stromal cells in the production of osteoclastogenic factors to elucidate the mechanism underlying extensive osteoclastic bone destruction. A murine myeloma cell line 5TGM1, which causes severe osteolysis, expresses alpha(4)beta(1)-integrin and tightly adheres to the mouse marrow stromal cell line ST2, which expresses the vascular cell adhesion molecule-1 (VCAM-1), a ligand for alpha(4)beta(1)-integrin. Co-cultures of 5TGM1 with primary bone marrow cells generated tartrate-resistant acid phosphatase-positive multinucleated bone-resorbing osteoclasts. Co-cultures of 5TGM1 with ST2 showed increased production of bone-resorbing activity and neutralizing antibodies against VCAM-1 or alpha(4)beta(1)-integrin inhibited this. The 5TGM1 cells contacting recombinant VCAM-1 produced increased osteoclastogenic and bone-resorbing activity. The activity was not blocked by the neutralizing antibody to known osteoclastogenic cytokines including interleukin (IL)-1, IL-6, tumor necrosis factor, or parathyroid hormone-related peptide. These data suggest that myeloma cells are responsible for producing osteoclastogenic activity and that establishment of direct contact with marrow stromal cells via alpha(4)beta(1)-integrin/VCAM-1 increases the production of this activity by myeloma cells. They also suggest that the presence of stromal cells may provide a microenvironment that allows exclusive colonization of myeloma cells in the bone marrow. (Blood. 2000;96:1953-1960)

journal_name

Blood

journal_title

Blood

authors

Michigami T,Shimizu N,Williams PJ,Niewolna M,Dallas SL,Mundy GR,Yoneda T

subject

Has Abstract

pub_date

2000-09-01 00:00:00

pages

1953-60

issue

5

eissn

0006-4971

issn

1528-0020

journal_volume

96

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Prevalence of heterozygotes for hemochromatosis in the white population of the United States.

    abstract::In previous studies, the prevalence of HLA-linked hemochromatosis, thought to be the most common genetic illness in whites, has been estimated by identifying homozygotes in the population. Because not all homozygotes express the disease phenotypically, the accuracy of these estimates is uncertain. We analyzed the dist...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McLaren CE,Gordeuk VR,Looker AC,Hasselblad V,Edwards CQ,Griffen LM,Kushner JP,Brittenham GM

    更新日期:1995-09-01 00:00:00

  • Long-awaited news for hepatic veno-occlusive disease.

    abstract::In this issue of Blood, Palomo et al provide new insight into the mechanism of action of defibrotide as an endothelial protective agent, while Richardson et al present the encouraging final results of the phase 3 clinical study of defibrotide for the treatment of severe hepatic veno-occlusive disease (VOD), showing a ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2016-02-694943

    authors: Arai S

    更新日期:2016-03-31 00:00:00

  • Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.

    abstract::We analyzed the involvement of Wiskott-Aldrich syndrome protein (WASp), a critical regulator of actin cytoskeleton remodeling, in the control of natural killer (NK)-cell migration. NK cells derived from patients with Wiskott-Aldrich syndrome/X-linked thrombocytopenia (WAS/XLT), carrying different mutations in the WASP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-235804

    authors: Stabile H,Carlino C,Mazza C,Giliani S,Morrone S,Notarangelo LD,Notarangelo LD,Santoni A,Gismondi A

    更新日期:2010-04-08 00:00:00

  • Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines.

    abstract::Nonsteroidal antiinflammatory agents (NSAIA) have been shown to exert potent chemopreventive activity against colon, lung, and breast cancers. In this study, we show that at pharmacological concentrations (1 to 3 mmol/L) sodium salicylate (Na-Sal) can potently induce programmed cell death in several human myeloid leuk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Klampfer L,Cammenga J,Wisniewski HG,Nimer SD

    更新日期:1999-04-01 00:00:00

  • Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

    abstract::Uniformly adopted response criteria are essential for assessment of therapies incorporating conventional chemotherapy and chemoimmunotherapy regimens. Recently, immunomodulatory agents, such as immune checkpoint inhibitors, have demonstrated impressive activity in a broad range of lymphoma histologies. However, these ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-05-718528

    authors: Cheson BD,Ansell S,Schwartz L,Gordon LI,Advani R,Jacene HA,Hoos A,Barrington SF,Armand P

    更新日期:2016-11-24 00:00:00

  • Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia.

    abstract::We report the results of unrelated cord blood transplantation (CBT) for 18 adult patients with de novo acute myeloid leukemia (AML). The median age was 43 years, the median weight was 55.2 kg, and the median number of cryopreserved nucleated cells was 2.51 x 107/kg. Seventeen patients had myeloid reconstitution and th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2420

    authors: Ooi J,Iseki T,Takahashi S,Tomonari A,Takasugi K,Shimohakamada Y,Yamada T,Ishii K,Ohno N,Nagamura F,Uchimaru K,Tojo A,Asano S

    更新日期:2004-01-15 00:00:00

  • Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

    abstract::To prospectively evaluate allogeneic stem cell transplantation (allo-SCT) for myeloma as part of first-line therapy, a donor versus no-donor analysis was performed of patients treated in the HOVON-50 study, a study that was originally designed to examine thalidomide combined with intensive therapy. Two hundred sixty p...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-11-393801

    authors: Lokhorst HM,van der Holt B,Cornelissen JJ,Kersten MJ,van Oers M,Raymakers R,Minnema MC,Zweegman S,Janssen JJ,Zijlmans M,Bos G,Schaap N,Wittebol S,de Weerdt O,Ammerlaan R,Sonneveld P

    更新日期:2012-06-28 00:00:00

  • Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes.

    abstract::Human mast cells in adult tissues have been thought to have limited, if any, proliferative potential. The current study examined mast cells obtained from adult skin and cultured in serum-free medium with recombinant human stem cell factor. During the first 4 weeks of culture, the percentages of mast cells increased fr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.7.2045

    authors: Kambe N,Kambe M,Kochan JP,Schwartz LB

    更新日期:2001-04-01 00:00:00

  • Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group.

    abstract::Timed sequencing of cycles of induction chemotherapy in acute myeloid leukemia (AML) has been proposed as a way to achieve maximal leukemic cell kill through recruitment and synchronization of residual neoplastic cells. Furthermore, whether intensive induction therapy should be continued in the presence of profound my...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Woods WG,Kobrinsky N,Buckley JD,Lee JW,Sanders J,Neudorf S,Gold S,Barnard DR,DeSwarte J,Dusenbery K,Kalousek D,Arthur DC,Lange BJ

    更新日期:1996-06-15 00:00:00

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    abstract::In an international collaborative study, a central histologic review identified 891 patients with essential thrombocythemia, strictly defined by World Health Organization criteria. After a median follow-up of 6.2 years, 109 (12%) patients experienced arterial (n = 79) or venous (n = 37) thrombosis. In multivariable an...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-02-339002

    authors: Carobbio A,Thiele J,Passamonti F,Rumi E,Ruggeri M,Rodeghiero F,Randi ML,Bertozzi I,Vannucchi AM,Antonioli E,Gisslinger H,Buxhofer-Ausch V,Finazzi G,Gangat N,Tefferi A,Barbui T

    更新日期:2011-06-02 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract::We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期:1987-12-01 00:00:00

  • A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.

    abstract::Interest in high-dose cytarabine (HDAC) for both induction and postremission therapy for acute myeloid leukemia (AML) prompted the Southwest Oncology Group (SWOG) to initiate a randomized trial comparing HDAC with standard-dose cytarabine (SDAC) for remission induction of previously untreated AML and to compare high-d...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Weick JK,Kopecky KJ,Appelbaum FR,Head DR,Kingsbury LL,Balcerzak SP,Bickers JN,Hynes HE,Welborn JL,Simon SR,Grever M

    更新日期:1996-10-15 00:00:00

  • Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

    abstract::Neutrophil gelatinase-associated lipocalin (NGAL) is a novel 25-kD protein of human neutrophils, that is in part covalently complexed with neutrophil gelatinase. However, both NGAL and gelatinase exist mainly in forms not associated with each other. An explanation for this phenomenon might be that the unassociated pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kjeldsen L,Bainton DF,Sengeløv H,Borregaard N

    更新日期:1994-02-01 00:00:00

  • Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

    abstract::Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363390

    authors: Betts BC,St Angelo ET,Kennedy M,Young JW

    更新日期:2011-11-10 00:00:00

  • Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells.

    abstract::Dendritic cell (DC) homeostasis in peripheral tissues reflect a balance between DC generation, migration, and death. The current model of DC ontogeny indicates that pre-cDCs are committed to become terminal conventional DCs (cDCs). Here, we report the unexpected finding that proliferating immunostimulatory CD11c(+) MH...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-11-392894

    authors: Diao J,Mikhailova A,Tang M,Gu H,Zhao J,Cattral MS

    更新日期:2012-05-24 00:00:00

  • Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.

    abstract::Conventional assays evaluating antitumor activity of immune effector cells have limitations that preclude their high-throughput application. We adapted the recently developed Compartment-Specific Bioluminescence Imaging (CS-BLI) technique to perform high-throughput quantification of innate antitumor activity and to sh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-348490

    authors: McMillin DW,Delmore J,Negri JM,Vanneman M,Koyama S,Schlossman RL,Munshi NC,Laubach J,Richardson PG,Dranoff G,Anderson KC,Mitsiades CS

    更新日期:2012-04-12 00:00:00

  • Enhanced stimulation of human bone marrow macrophage colony formation in vitro by recombinant human macrophage colony-stimulating factor in agarose medium and at low oxygen tension.

    abstract::Recombinant (r) and natural human (h) macrophage colony-stimulating factor (M-CSF, CSF-1) have been considered poor stimulators of macrophage progenitor cells present in human marrow, although they are potent stimulators of these cells in mouse marrow. We compared the growth characteristics of rhM-CSF-responsive human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE,Cooper S,Lu L,Miller ME,Langefeld CD,Ralph P

    更新日期:1990-07-15 00:00:00

  • Characterization of monoclonal antibodies that recognize canine CD34.

    abstract::Using a polyclonal antiserum against canine CD34, we previously found that CD34 is expressed on canine bone marrow progenitor cells in a manner analogous to that found in humans. To further characterize CD34+ cells and to facilitate preclinical canine stem cell transplant studies, monoclonal antibodies (MoAbs) were ra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McSweeney PA,Rouleau KA,Wallace PM,Bruno B,Andrews RG,Krizanac-Bengez L,Sandmaier BM,Storb R,Wayner E,Nash RA

    更新日期:1998-03-15 00:00:00

  • Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.

    abstract::The efficacy and safety of zanolimumab in patients with refractory cutaneous T-cell lymphoma (CTCL) have been assessed in two phase 2, multicenter, prospective, open-label, uncontrolled clinical studies. Patients with treatment refractory CD4(+) CTCL (mycosis fungoides [MF], n = 38; Sézary syndrome [SS], n = 9) receiv...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2006-12-062877

    authors: Kim YH,Duvic M,Obitz E,Gniadecki R,Iversen L,Osterborg A,Whittaker S,Illidge TM,Schwarz T,Kaufmann R,Cooper K,Knudsen KM,Lisby S,Baadsgaard O,Knox SJ

    更新日期:2007-06-01 00:00:00

  • Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.

    abstract::FLT3 is constitutively activated by internal tandem duplications (ITDs) in the juxtamembrane domain or by activation loop mutations in acute myeloid leukemia (AML). We tested the sensitivity of 8 activation loop mutations to the small molecule FLT3 inhibitor, MLN518. Each FLT3 activation loop mutant, including D835Y, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4446

    authors: Clark JJ,Cools J,Curley DP,Yu JC,Lokker NA,Giese NA,Gilliland DG

    更新日期:2004-11-01 00:00:00

  • Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

    abstract::Thalidomide (Thal) can overcome drug resistance in multiple myeloma (MM) but is associated with somnolence, constipation, and neuropathy. In previous in vitro studies, we have shown that the potent immunomodulatory derivative of thalidomide (IMiD) CC-5013 induces apoptosis or growth arrest even in resistant MM cell li...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-03-0996

    authors: Richardson PG,Schlossman RL,Weller E,Hideshima T,Mitsiades C,Davies F,LeBlanc R,Catley LP,Doss D,Kelly K,McKenney M,Mechlowicz J,Freeman A,Deocampo R,Rich R,Ryoo JJ,Chauhan D,Balinski K,Zeldis J,Anderson KC

    更新日期:2002-11-01 00:00:00

  • Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.

    abstract::Complex molecular mechanisms control B-cell fate to become a memory or a plasma cell. Interleukin-24 (IL-24) is a class II family cytokine of poorly understood immune function that regulates the cell cycle. We previously observed that IL-24 is strongly expressed in leukemic memory-type B cells. Here we show that IL-24...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-220251

    authors: Maarof G,Bouchet-Delbos L,Gary-Gouy H,Durand-Gasselin I,Krzysiek R,Dalloul A

    更新日期:2010-03-04 00:00:00

  • An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia.

    abstract::Myeloperoxidase (MPO) catalyzes a reaction between chloride and hydrogen peroxide to generate hypochlorous acid and other reactive compounds that have been linked to DNA damage. The MPO gene is expressed at high levels in normal myeloid precursors and in acute myeloid leukemias (AMLs) which are clonal derivatives of m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reynolds WF,Chang E,Douer D,Ball ED,Kanda V

    更新日期:1997-10-01 00:00:00

  • Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that accounts for ∼20% of ALL cases. Intensive chemotherapy regimens result in cure rates >85% in children and <50% in adults, warranting a search of novel therapeutic strategies. Although immune-based therapies have tremendously improved the trea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003801

    authors: Tran Quang C,Zaniboni B,Humeau R,Lengliné E,Dourthe ME,Ganesan R,Singh S,Scheer JM,Asnafi V,Ghysdael J

    更新日期:2020-09-10 00:00:00

  • Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation.

    abstract::Idiopathic pneumonia syndrome (IPS) is a relatively common, frequently fatal clinical entity, characterized by noninfectious acute lung inflammation following allogeneic stem cell transplantation (SCT), the mechanisms of which are unclear. In this study, we demonstrate that immune suppression with cyclosporin after SC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-590232

    authors: Varelias A,Gartlan KH,Kreijveld E,Olver SD,Lor M,Kuns RD,Lineburg KE,Teal BE,Raffelt NC,Cheong M,Alexander KA,Koyama M,Markey KA,Sturgeon E,Leach J,Reddy P,Kennedy GA,Yanik GA,Blazar BR,Tey SK,Clouston AD,MacDon

    更新日期:2015-04-09 00:00:00

  • Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways.

    abstract::The cyclin-dependent kinase inhibitor p21WAF1/Cip1 and Survivin enhance granulocyte macrophage colony-forming unit (CFU-GM) cell cycle and proliferation and have been implicated as antiapoptotic proteins. We investigated the relationships between p21 and Survivin in primary CFU-GM and c-kit+, lineage-negative (Lin-) c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1756

    authors: Fukuda S,Mantel CR,Pelus LM

    更新日期:2004-01-01 00:00:00

  • Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro.

    abstract::Leukocyte transendothelial migration (TEM) is a critical event during inflammation. CD47 has been implicated in myeloid cell migration across endothelium and epithelium. CD47 binds to signal regulatory protein (SIRP), SIRPalpha and SIRPgamma. So far, little is known about the role of endothelial CD47 in T-cell TEM in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-134429

    authors: Stefanidakis M,Newton G,Lee WY,Parkos CA,Luscinskas FW

    更新日期:2008-08-15 00:00:00

  • K-Ras is essential for normal fetal liver erythropoiesis.

    abstract::In vitro studies suggest that Ras activation is necessary for erythroid cell development. However, genetic inactivation of the Ras isoforms H-Ras, N-Ras, and K-Ras in mice reportedly did not affect adult or fetal erythropoiesis, though K-Ras(-/-) embryos were anemic. Given these discrepancies, we performed a more deta...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-2021

    authors: Khalaf WF,White H,Wenning MJ,Orazi A,Kapur R,Ingram DA

    更新日期:2005-05-01 00:00:00

  • Quantitation of adenosine-5'-triphosphate used for phosphoinositide metabolism in human erythrocytes.

    abstract::The human erythrocyte actively phosphorylates and dephosphorylates phosphatidylinositol present in the membrane in an apparent "futile cycle." Recent reports have proposed that this phosphorylation/dephosphorylation cycle is a significant consumer of adenosine-5'-triphosphate (ATP) in the erythrocyte. This study detai...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dale GL

    更新日期:1985-11-01 00:00:00

  • Molecular interactions between Hb alpha-G Philadelphia, HbC, and HbS: phenotypic implications for SC alpha-G Philadelphia disease.

    abstract::We show here that alpha2(G-Phila.) beta2(C) has an increased rate of crystal nucleation compared to alpha2 beta2(C) (HbC). We conclude from this finding that position alpha68, the mutation site of alpha2(G-Phila.) beta2 (HbG(Philadelphia)), is a contact site in the crystal of HbC. In addition, that HbS enhances HbC cr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lawrence C,Hirsch RE,Fataliev NA,Patel S,Fabry ME,Nagel RL

    更新日期:1997-10-01 00:00:00